This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fruehwald-Schultes, B. Articles by Peters, A. Search for Related Content PubMed PubMed Citation Articles by Fruehwald-Schultes, B. Articles by Peters, A.

Metformin Does Not Adversely Affect Hormonal and Symptomatic Responses to Recurrent Hypoglycemia

Departments of Internal Medicine I and Neuroendocrinology, University of Luebeck, D-23538 Luebeck, Germany

Address all correspondence and requests for reprints to: Bernd Fruehwald-Schultes, M.D., Medical Department of Internal Medicine I, University Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany. E-mail: fruehwal{at}kfg.mu-luebeck.de

Abstract

Body weight gain and severe hypoglycemia are the major adverse effects of insulin therapy in type 2 diabetic patients. Metformin has been shown to prevent insulin therapy-induced body weight gain when used in combination with insulin. However, the effects of metformin on hormonal and symptomatic responses to hypoglycemia mediating hypoglycemia awareness have not been assessed to date. Fifteen young healthy men were treated with 850 mg metformin and placebo twice daily for a 16-d period in a double blind, cross-over design. On the last 2 d of the treatment period, the subjects underwent three hypoglycemic clamp experiments, with the first and the last performed with identical patterns of plasma glucose decrease. Differences between the effects of metformin and placebo (effect of metformin) as well as between first and last hypoglycemic clamps (effect of antecedent hypoglycemia) were assessed. Antecedent hypoglycemia significantly reduced epinephrine, ACTH, cortisol, glucagon, GH, and symptomatic responses to hypoglycemia (P < 0.05 for all variables). There was no detectable effect of metformin on epinephrine, norepinephrine, ACTH, cortisol, glucagon, or autonomic symptomatic response to hypoglycemia (P > 0.05 for all comparisons), except that metformin slightly increased the response of GH to hypoglycemia (P = 0.039). The latter finding may be due to an IGF-I-reducing effect of metformin, as after 14 d of metformin treatment baseline levels of IGF-I were significantly lower than in the placebo condition (236.9 ± 13.9 vs. 263.2 ± 14.4 µg/liter; P = 0.015). The data indicate that metformin does not adversely affect hormonal and symptomatic responses to hypoglycemia. This finding appears to be relevant with regard to the safety of the combination of metformin with insulin therapy.

This article has been cited by other articles:

				S. M. Schmid, K. Jauch-Chara, M. Hallschmid, and B. Schultes Mild Sleep Restriction Acutely Reduces Plasma Glucagon Levels in Healthy Men J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 5169 - 5173. [Abstract] [Full Text] [PDF]

				S. M. Schmid, M. Hallschmid, K. Jauch-Chara, N. Bandorf, J. Born, and B. Schultes Sleep Loss Alters Basal Metabolic Hormone Secretion and Modulates the Dynamic Counterregulatory Response to Hypoglycemia J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3044 - 3051. [Abstract] [Full Text] [PDF]

				A. Omari, D. K Yue, and S. M Twigg Exercise, metformin and hypoglycaemia: a neglected entity The British Journal of Diabetes & Vascular Disease, March 1, 2005; 5(2): 106 - 108. [Abstract] [PDF]

				B. Schultes, K. M. Oltmanns, W. Kern, H. L. Fehm, J. Born, and A. Peters Modulation of Hunger by Plasma Glucose and Metformin J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1133 - 1141. [Abstract] [Full Text] [PDF]